| Ensuring optimal insulin utilization in the hospital setting: role of the pharmacist. | |
| | |
MedLine Citation:
|
PMID: 20689152 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To summarize essential information for the hospital pharmacist to support the safe and effective use of insulin for the treatment of inpatient hyperglycemia. SUMMARY: Ensuring optimal insulin utilization in the hospital setting requires collaboration of a multidisciplinary team, including physicians (and endocrinologists specifically), nurses, pharmacists, dieticians, diabetes educators, laboratory staff, quality management staff, and others. The role of pharmacists in this multidisciplinary team is to assist in the standardization of insulin therapy via selection of appropriate insulin treatment protocols, participate in formulary management of insulin products, and contribute to the development of order sets and policies and procedures to minimize the risk of medication errors and misadventures. In addition, pharmacists can provide guidelines or treatment recommendations in special situations, such as those involving patients receiving enteral or parenteral nutrition or high-dose corticosteroids and the transition from i.v. to subcutaneous insulin therapy. Education of patients and providers is another key role for pharmacists. Nurses are important allies in the effort to ensure safe insulin use, as they are at the bedside of patients administering and adjusting insulin therapy. Recommendations are provided for the safe and effective use of insulin for the treatment of inpatient hyperglycemia. CONCLUSION: Pharmacists are an integral part of the multidisciplinary team ensuring the safe and effective implementation of inpatient hyperglycemic control and insulin usage. |
| | |
Authors:
|
Janet L Kelly |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists Volume: 67 ISSN: 1535-2900 ISO Abbreviation: Am J Health Syst Pharm Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-08-06 Completed Date: 2010-11-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9503023 Medline TA: Am J Health Syst Pharm Country: United States |
Other Details:
|
Languages: eng Pagination: S9-16 Citation Subset: IM |
Affiliation:
|
University of Washington Medical Center, 1959 NE Pacific Street, Box 356015, Seattle, WA 98195, USA. rxpress@u.washington.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Humans Hyperglycemia / drug therapy, prevention & control Hypoglycemic Agents / administration & dosage*, therapeutic use Inpatients Insulin / administration & dosage*, therapeutic use Patient Care Team Pharmacists* Pharmacy Service, Hospital* Professional Role* |
| Chemical | |
Reg. No./Substance:
|
0/Hypoglycemic Agents; 11061-68-0/Insulin |
| Comments/Corrections | |
Erratum In:
|
Am J Health Syst Pharm. 2010 Nov 1;67(21):1794 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Reexamining the evidence for inpatient glucose control: new recommendations for glycemic targets.
Next Document: Cognitive defusion versus thought distraction: a clinical rationale, training, and experiential exer...